See more funds from Lazard Fund Managers
See more funds in the Global Equity Income sector
See more funds managed by: Andrew Lacey
Fund Overview |
|
|---|---|
| Unit Price |
105.00p
24/05/2012 |
| Standard Initial Charge | n/a |
| TQ Invest Discount | 0.00% |
| Initial Charge Through TQ Invest | n/a |
| Saving 2 | n/a |
| Annual Management Charge | 1.00% |
| Total Expense Ratio | 1.08% |
| Fund size | £181,849,984 |
| Usable in ISA | Yes |
| Holding | Weighting |
|---|---|
| Murgitroyd Group Plc | 3.40% |
| Henderson European Equity Enhanced I | 3.10% |
| Goldcorp Inc | 2.90% |
| Etfs Physical Gold 0% Secured Nts Aud | 2.90% |
| Hikma Pharmaceuticals | 2.90% |
| Toyo Suisan Kaisha | 2.70% |
| Hi-Lex Corp | 2.70% |
| Krung Thai Bank Pcl Common Stock Thb5.15 | 2.40% |
| Russell Investment Co Plc Pacific Basin Equity Fd Class`P`Shs Gbp | 2.40% |
| Smrt Corporation | 2.20% |
| Sector | Weighting |
|---|---|
| Offices - Property | 27.50% |
| Net Current Assets | 18.40% |
| Retail - Property | 18.00% |
| Money Market | 14.30% |
| Unquoted Investments | 10.60% |
| Commercial Paper | 4.20% |
| Warehousing & Real Estate | 4.10% |
| Food Producers | 3.00% |
| Region | Weighting |
|---|---|
| North America | 33.00% |
| Continental Europe | 22.10% |
| Asia | 8.20% |
| Americas | 7.90% |
| Middle East/ Africa | 7.60% |
| Asia Pacific | 6.90% |
| Money Market | 4.20% |
| European Emerging Markets | 4.00% |
| Uk | 3.90% |
| Japan | 2.20% |
| Asset Type | Weighting |
|---|---|
| North American Equities | 33.00% |
| European Equities | 26.10% |
| Global Emerging Market Equities | 16.10% |
| Asia Pacific Equities | 9.10% |
| International Equities | 7.60% |
| Money Market | 4.20% |
| Uk Equities | 3.90% |
1Discount for an ISA investment through the Cofunds platform.
2Saving based on a typical ISA investment of £11,280.00 through the Cofunds platform.
Data provided by 
The value of this investment and the income from it can go down as well as up. Past performance should not be regarded as a guide to the future. The investment described may not be suitable for all recipients and this factsheet does not constitute personalised investment advice. No liability is accepted for any loss arising from errors or omissions.